June 21, 2010

NIH Needs Sunshine Law Enforcement

CORRECTED/ REVISED This is a follow-up to our Infomail about the revelations in an investigative report by

Read More
NIH Needs Sunshine Law Enforcement

April 20, 2009

AHRP Letter to Harvard Re: Dr. Biederman’s Research

ALLIANCE FOR HUMAN RESEARCH PROTECTION A catalyst for public debate 142 West End Avenue Suite 28P New

Read More
AHRP Letter to Harvard Re: Dr. Biederman’s Research

April 27, 2008

Letter of Complaint Re: FDA Double Agent

  ALLIANCE FOR HUMAN RESEARCH PROTECTION www.ahrp.org 142 West End Avenue, Suite 28P New York, NY 10023

Read More
Letter of Complaint Re: FDA Double Agent

November 6, 2006

Psychiatry News: High Cost of Nondisclosure

A guest editorial in Psychiatry News, by the two psychiatrists who first blew the whistle on an

Read More
Psychiatry News: High Cost of Nondisclosure

October 26, 2006

FDA’s Double Standard Re: Advisory Committee Membership

FDA’s Double Standard Re: Advisory Committee Membership Mon, 15 Nov 2004 FDA’s inexplicable actions–the latest being the

Read More
FDA’s Double Standard Re: Advisory Committee Membership

October 26, 2006

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT Sun, 14

Read More
Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT

October 26, 2006

Infomail Archive

Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA

Read More
Infomail Archive

October 26, 2006

Featured News

AHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH

Read More
Featured News

October 26, 2006

Statement by Vera Hassner Sharav, President AHRP: 2/2/04 Press Briefing

THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023

Read More
Statement by Vera Hassner Sharav, President AHRP: 2/2/04 Press Briefing

October 26, 2006

Article

Letter from David Healy, MD to Peter J. Pitts Executive Summary of suicidal evidence not addressed by

Read More
Article

October 26, 2006

Infomail Archive

Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA

Read More
Infomail Archive

October 26, 2006

Senate Finance Committee Investigating FDA brain stimulation device approval – WSJ

Senate Finance Committee Investigating FDA brain stimulation device approval – WSJ Thu, 19 May 2005 Another major

Read More
Senate Finance Committee Investigating FDA brain stimulation device approval – WSJ

October 26, 2006

NIMH Offers Grants to Study SSRI relation to Suicidality – FDA to Examine SSRI- Suicide in Adults

NIMH Offers Grants to Study SSRI relation to Suicidality_FDA to Examine SSRI- Suicide in Adults Mon, 14

Read More
NIMH Offers Grants to Study SSRI relation to Suicidality – FDA to Examine SSRI- Suicide in Adults

October 26, 2006

Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – Leo

Reply to the American College of Neuropharmacology’s Report on SSRI and Suicidal Behavior in Children Jonathan Leo,

Read More
Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – Leo